Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy

Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells (PBSC) doses of less than 1 × 106/kg CD34+ cells o...

Full description

Bibliographic Details

Published in:	Case Reports in Oncological Medicine
Main Authors:	Maxim Yankelevich, Sureyya Savasan, Igor Dolgopolov, Roland Chu, George Mentkevich
Format:	Article
Language:	English
Published:	Wiley 2017-01-01
Online Access:	http://dx.doi.org/10.1155/2017/4184879